.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Glioblastoma multiforme (GBM) is a highly aggressive and heterogeneous brain cancer. Because of its complex nature, traditional treatments often fail to provide long-term survival. However, researchers are now focusing on targeted GBM therapy to improve clinical outcomes. By utilizing receptors overexpressed on the surface of tumor cells, scientists can deliver medication more precisely.
One major focus of this research involves receptors like interleukin-13 receptor alpha 2 (IL-13Rα2) and the transferrin receptor (TfR). These biomarkers allow for specific binding of drug-loaded carriers. Consequently, this approach reduces the exposure of healthy brain tissue to toxic chemotherapy. Furthermore, integrins and receptor tyrosine kinases (RTKs) serve as additional vital targets for these innovative platforms.
Modern nanotechnology plays a critical role in these advancements. Clinicians are exploring nanoparticles such as liposomes and gold nanostructures. These carriers are functionalized with specialized ligands like RGD peptides. These ligands act as a GPS, guiding drugs like temozolomide and gefitinib directly to the tumor. As a result, early-phase clinical trials are already showing promising safety and efficacy profiles.
Despite these successes, some challenges remain. For example, nanoparticle-associated cytotoxicity and off-target effects can limit clinical translation. Therefore, future research must prioritize the development of biodegradable and biocompatible nanomaterials. Additionally, exploring underexplored receptors like periostin (POSTN) could reveal new pathways for overcoming therapeutic resistance.
Commonly targeted receptors include IL-13Rα2, TfR, and integrins. These are highly expressed on tumor cells compared to normal brain tissue, allowing for selective drug delivery.
The main hurdles include crossing the blood-brain barrier effectively and minimizing nanoparticle-associated toxicity. Researchers are working on biocompatible designs to solve these issues.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always consult a qualified healthcare provider for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
Hadri SH et al. Exploring the potential of multiple receptors overexpressed on glioblastoma cells as biomarkers for the targeted therapy; a review. Ther Deliv. 2026 Jun 11. doi: 10.1080/20415990.2026.2682697. PMID: 42273826.
Rahman MA et al. Progress in Drug Delivery Systems Based on Nanoparticles for Improved Glioblastoma Therapy: Addressing Challenges and Investigating Opportunities. Cancers (Basel). 2025 Feb 19;17(4):701. doi: 10.3390/cancers17040701. PMID: 40002294.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Glioblastoma multiforme remains a major clinical challenge. However, new research into targeted GBM therapy using specific receptors and nanoparticle-based delivery systems offers a path toward more effective and less toxic treatments. This review highlights recent progress and future opportunities.
last month
The Food Safety and Standards Authority of India (FSSAI) has rejected industry appeals and directed beverage manufacturers to remove the term 'energy drink' and unapproved therapeutic claims within 90 days. This regulation aims to curb misbranding and ensure clear labeling across commercial food products.
Today
Johnson & Johnson announced a $5.5 billion settlement to resolve nearly 69,000 lawsuits alleging its talc-based baby powder caused ovarian cancer. This comprehensive deal covers 99.75% of active claims. Read about the legal strategy, scientific evidence on talc exposure, and clinical counseling for patients.
Today
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
4 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
4 days back
A UK Biobank study of 471,540 participants reveals that metabolic syndrome increases incident gastric cancer risk by 36% (HR=1.36). A positive trend was observed with accumulating metabolic components, with waist circumference showing the strongest association, highlighting modifiable risk targets.
4 days back
